N

NovoCure Limited

D
NVCR
USD
-0.455
(-2.5124%)
Market Closed
45,498.00
Volume
-1.32
EPS
-
Div Yield
-11.174051
P/E
1,910,579,785.95
Market Cap
Today
-2.5124%
1 Week
16.343%
1 Month
20.759%
6 Months
13.720%
12 Months
37.340%
Year To Date
18.173%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
M
MMSI
3.25
(3.2901%)
USD
ISRG
ISRG
4.01
(0.7705%)
USD
I
ICUI
-0.22
(-0.123%)
USD
AAPL
AAPL
4.23
(1.893%)
USD
AMZN
AMZN
10.72
(5.3734%)
USD
GOOGL
GOOGL
4.3
(2.436%)
USD
TSLA
TSLA
8.33
(2.8876%)
USD
IDXX
IDXX
3.14
(0.7298%)
USD

Title:
NovoCure Limited

Sector:
Healthcare
Industry:
Medical Devices
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatmentof solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derivesmajority of its revenue from the United States and rest from Germany, Japan and other markets.
Do you need help or have a question?
Contact Us